Distinct Microbial Communities Trigger Colitis Development upon Intestinal Barrier Damage via Innate or Adaptive Immune Cells

Cell Reports

Volumn 21, Issue 4, 2017, Pages 994-1008

  Roy, Urmi ^a   Gálvez, Eric J C ^a   Iljazovic, Aida ^a   Lesker, Till Robin ^a   Błażejewski, Adrian J ^a   Pils, Marina C ^a   Heise, Ulrike ^a   Huber, Samuel ^b   Flavell, Richard A ^c,d   Strowig, Till ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

adaptive colitis; colitis pathogenesis; DSS colitis; gut microbiota; IBD; innate colitis

Indexed keywords

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CHEMICAL INJURY; COLITIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENTERITIS; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTESTINE INJURY; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; FEMALE; IMMUNOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; MALE; MICROBIOLOGY; ULCERATIVE COLITIS;

ADAPTIVE IMMUNITY; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; FEMALE; GASTROINTESTINAL MICROBIOME; IMMUNITY, INNATE; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL;

EID: 85031998982     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.09.097     Document Type: Article

References (48)

1. Anderson, M.J., A new method for non-parametric multivariate analysis of variance. Austral. Ecol. 26 (2001), 32–46.
2. Bloom, S.M., Bijanki, V.N., Nava, G.M., Sun, L., Malvin, N.P., Donermeyer, D.L., Dunne, W.M. Jr., Allen, P.M., Stappenbeck, T.S., Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9 (2011), 390–403.
3. Börnigen, D., Morgan, X.C., Franzosa, E.A., Ren, B., Xavier, R.J., Garrett, W.S., Huttenhower, C., Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med., 5, 2013, 65.
4. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Peña, A.G., Goodrich, J.K., Gordon, J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
5. Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Lozupone, C.A., Turnbaugh, P.J., Fierer, N., Knight, R., Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2011), 4516–4522.
6. Chassaing, B., Aitken, J.D., Malleshappa, M., Vijay-Kumar, M., Dextran sulfate sodium (DSS)-induced colitis in mice. Curr. Protoc. Immunol., 104, 2014 Unit 15.25.
7. Chen, Y., Chou, K., Fuchs, E., Havran, W.L., Boismenu, R., Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc. Natl. Acad. Sci. USA 99 (2002), 14338–14343.
8. Cho, J.H., The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 8 (2008), 458–466.
9. Clemente, J.C., Ursell, L.K., Parfrey, L.W., Knight, R., The impact of the gut microbiota on human health: an integrative view. Cell 148 (2012), 1258–1270.
10. Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., Huot, L., Grandjean, T., Bressenot, A., Delanoye-Crespin, A., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123 (2013), 700–711.
11. Devkota, S., Wang, Y., Musch, M.W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D.A., Jabri, B., Chang, E.B., Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487 (2012), 104–108.
12. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
13. Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., Peaper, D.R., Bertin, J., Eisenbarth, S.C., Gordon, J.I., Flavell, R.A., NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145 (2011), 745–757.
14. Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M.J., Valles-Colomer, M., Vandeputte, D., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
15. Feng, T., Wang, L., Schoeb, T.R., Elson, C.O., Cong, Y., Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J. Exp. Med. 207 (2010), 1321–1332.
16. Fox, J.G., Ge, Z., Whary, M.T., Erdman, S.E., Horwitz, B.H., Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol. 4 (2011), 22–30.
17. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104 (2007), 13780–13785.
18. Gagliani, N., Amezcua Vesely, M.C., Iseppon, A., Brockmann, L., Xu, H., Palm, N.W., de Zoete, M.R., Licona-Limón, P., Paiva, R.S., Ching, T., et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523 (2015), 221–225.
19. Garrett, W.S., Gallini, C.A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M.L., Punit, S., Karlsson, M., Bry, L., Glickman, J.N., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8 (2010), 292–300.
20. Gevers, D., Kugathasan, S., Denson, L.A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S.J., Yassour, M., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
21. Honda, K., Littman, D.R., The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 30 (2012), 759–795.
22. Hu, S., Peng, L., Kwak, Y.T., Tekippe, E.M., Pasare, C., Malter, J.S., Hooper, L.V., Zaki, M.H., The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense. Cell Rep. 13 (2015), 1922–1936.
23. Imhann, F., Vich Vila, A., Bonder, M.J., Fu, J., Gevers, D., Visschedijk, M.C., Spekhorst, L.M., Alberts, R., Franke, L., van Dullemen, H.M., et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut, 2016, 10.1136/gutjnl-2016-312135 Published online October 8, 2016.
24. Ivanov, I.I.I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V.S., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139 (2009), 485–498.
25. Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Schumm, L.P., Sharma, Y., Anderson, C.A., et al., International IBD Genetics Consortium (IIBDGC). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
26. Kamada, N., Seo, S.-U., Chen, G.Y., Núñez, G., Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13 (2013), 321–335.
27. Kaser, A., Zeissig, S., Blumberg, R.S., Inflammatory bowel disease. Annu. Rev. Immunol. 28 (2010), 573–621.
28. Keubler, L.M., Buettner, M., Häger, C., Bleich, A., A Multihit Model: Colitis Lessons from the Interleukin-10-deficient Mouse. Inflamm. Bowel Dis. 21 (2015), 1967–1975.
29. Laukens, D., Brinkman, B.M., Raes, J., De Vos, M., Vandenabeele, P., Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol. Rev. 40 (2016), 117–132.
30. Levy, M., Thaiss, C.A., Zeevi, D., Dohnalová, L., Zilberman-Schapira, G., Mahdi, J.A., David, E., Savidor, A., Korem, T., Herzig, Y., et al. Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling. Cell 163 (2015), 1428–1443.
31. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102 (2005), 11070–11075.
32. Mamantopoulos, M., Ronchi, F., Van Hauwermeiren, F., Vieira-Silva, S., Yilmaz, B., Martens, L., Saeys, Y., Drexler, S.K., Yazdi, A.S., Raes, J., et al. Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition. Immunity 47 (2017), 339–348.e4.
33. McMurdie, P.J., Holmes, S., phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE, 8, 2013, e61217.
34. Neurath, M.F., Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14 (2014), 329–342.
35. Ostanin, D.V., Bao, J., Koboziev, I., Gray, L., Robinson-Jackson, S.A., Kosloski-Davidson, M., Price, V.H., Grisham, M.B., T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296 (2009), G135–G146.
36. Petersen, C., Round, J.L., Defining dysbiosis and its influence on host immunity and disease. Cell. Microbiol. 16 (2014), 1024–1033.
37. Rausch, P., Basic, M., Batra, A., Bischoff, S.C., Blaut, M., Clavel, T., Gläsner, J., Gopalakrishnan, S., Grassl, G.A., Günther, C., et al. Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities. Int. J. Med. Microbiol. 306 (2016), 343–355.
38. Roberts, M.E., Bishop, J.L., Fan, X., Beer, J.L., Kum, W.W.S., Krebs, D.L., Huang, M., Gill, N., Priatel, J.J., Finlay, B.B., Harder, K.W., Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens. J. Immunol. 193 (2014), 5249–5263.
39. Saleh, M., Elson, C.O., Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity 34 (2011), 293–302.
40. Schaubeck, M., Clavel, T., Calasan, J., Lagkouvardos, I., Haange, S.B., Jehmlich, N., Basic, M., Dupont, A., Hornef, M., Von Bergen, M., et al. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut 65 (2016), 225–237.
41. Schwab, C., Berry, D., Rauch, I., Rennisch, I., Ramesmayer, J., Hainzl, E., Heider, S., Decker, T., Kenner, L., Müller, M., et al. Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. ISME J. 8 (2014), 1101–1114.
42. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., Metagenomic biomarker discovery and explanation. Genome Biol., 12, 2011, R60.
43. Stappenbeck, T.S., Virgin, H.W., Accounting for reciprocal host-microbiome interactions in experimental science. Nature 534 (2016), 191–199.
44. Turnbaugh, P.J., Bäckhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
45. Turnbaugh, P.J., Ridaura, V.K., Faith, J.J., Rey, F.E., Knight, R., Gordon, J.I., The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med., 1, 2009 6ra14.
46. Villarino, N.F., LeCleir, G.R., Denny, J.E., Dearth, S.P., Harding, C.L., Sloan, S.S., Gribble, J.L., Campagna, S.R., Wilhelm, S.W., Schmidt, N.W., Composition of the gut microbiota modulates the severity of malaria. Proc. Natl. Acad. Sci. USA 113 (2016), 2235–2240.
47. Wang, Q., Garrity, G.M., Tiedje, J.M., Cole, J.R., Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73 (2007), 5261–5267.
48. Yang, Y., Torchinsky, M.B., Gobert, M., Xiong, H., Xu, M., Linehan, J.L., Alonzo, F., Ng, C., Chen, A., Lin, X., et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 510 (2014), 152–156.